Asunercept as an innovative therapeutic approach for recurrent glioblastoma and other malignancies

Andriy Krendyukov, Christian GieffersApogenix AG, Heidelberg, GermanyCorrespondence: Andriy KrendyukovApogenix AG, Im Neuenheimer Feld 584, Heidelberg 69120, GermanyEmail andriy.krendyukov@apogenix.comAbstract: Glioblastoma is the most common and aggressive malignant tumor of the central nervous sys...

Full description

Bibliographic Details
Main Authors: Krendyukov A, Gieffers C
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/asunercept-as-an-innovative-therapeutic-approach-for-recurrent-gliobla-peer-reviewed-article-CMAR